Antagonists of IL-6 to raise albumin and/or lower CRP

Details for Australian Patent Application No. 2009323002 (hide)

Owner Alder Biopharmaceuticals, Inc.

Inventors Smith, Jeffrey T. L.

Agent Watermark

Pub. Number AU-A-2009323002

PCT Pub. Number WO2010/065072

Priority 12/399,156 06.03.09 US; 61/117,861 25.11.08 US; 61/117,839 25.11.08 US; 12/391,717 24.02.09 US; 61/117,811 25.11.08 US; 12/502,581 14.07.09 US; 12/391,615 24.02.09 US; 12/366,567 05.02.09 US

Filing date 24 November 2009

Wipo publication date 10 June 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/065072 Priority application(s): WO2010/065072

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009323004-Product stabilizing conveyor system and method

2009322999-Compositions comprising reninangiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of reninangiotensin aldosterone system related disorders